ATE328100T1 - Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren - Google Patents

Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren

Info

Publication number
ATE328100T1
ATE328100T1 AT95941756T AT95941756T ATE328100T1 AT E328100 T1 ATE328100 T1 AT E328100T1 AT 95941756 T AT95941756 T AT 95941756T AT 95941756 T AT95941756 T AT 95941756T AT E328100 T1 ATE328100 T1 AT E328100T1
Authority
AT
Austria
Prior art keywords
transcomplementation
cell line
packaging cell
retrovirus vectors
defective retrovirus
Prior art date
Application number
AT95941756T
Other languages
English (en)
Inventor
Odile Cohen-Haguenauer
Original Assignee
Odile Cohen-Haguenauer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Odile Cohen-Haguenauer filed Critical Odile Cohen-Haguenauer
Application granted granted Critical
Publication of ATE328100T1 publication Critical patent/ATE328100T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
    • C12N2740/17022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
    • C12N2740/17051—Methods of production or purification of viral material
    • C12N2740/17052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hybrid Cells (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Character Discrimination (AREA)
  • Manufacturing Of Printed Wiring (AREA)
  • Circuits Of Receivers In General (AREA)
  • Photovoltaic Devices (AREA)
  • Semiconductor Memories (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95941756T 1994-11-30 1995-11-30 Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren ATE328100T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9414406A FR2727429B1 (fr) 1994-11-30 1994-11-30 Lignees d'encapsidation et vecteurs d'expression pour la transcomplementation de vecteurs retroviraux defectifs

Publications (1)

Publication Number Publication Date
ATE328100T1 true ATE328100T1 (de) 2006-06-15

Family

ID=9469343

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941756T ATE328100T1 (de) 1994-11-30 1995-11-30 Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren

Country Status (10)

Country Link
US (1) US6432709B1 (de)
EP (1) EP0796338B1 (de)
JP (1) JPH10510163A (de)
AT (1) ATE328100T1 (de)
AU (1) AU4306996A (de)
CA (1) CA2206574A1 (de)
DE (1) DE69535024D1 (de)
FR (1) FR2727429B1 (de)
IL (1) IL116216A (de)
WO (1) WO1996017071A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU729908B2 (en) * 1996-03-25 2001-02-15 Transgene S.A. Antitumor cellular compositions expressing at least three transgenes
WO1997035996A1 (en) * 1996-03-25 1997-10-02 Transgene S.A. Packaging cell line based on human 293 cells
FR2751345B1 (fr) 1996-07-16 1998-09-18 Univ Paris Curie Lignees d'encapsidation hautement productrices
US6902929B1 (en) 1997-02-27 2005-06-07 Bundesrepublik Deutschland Last Represented By The President Of The Paul-Ehrlich-Instituts Retroviral vectors, methods for their preparation and their use for gene transfer into CD4-positive cells
WO1999037331A1 (en) * 1998-01-21 1999-07-29 The Regents Of The University Of Michigan Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650764A (en) * 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
ATE142268T1 (de) 1988-05-17 1996-09-15 Sloan Kettering Inst Cancer Retroviraler vektor
WO1990002797A1 (en) * 1988-09-15 1990-03-22 North Carolina State University Self-inactivating, replication defective, retroviral vectors and helper cells for producing the same
US5082670A (en) 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5124263A (en) * 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
AU7312891A (en) 1990-02-12 1991-09-03 Board Of Regents, The University Of Texas System Satellite cell proliferation in adult skeletal muscle
JPH06500923A (ja) * 1990-09-21 1994-01-27 カイロン　コーポレイション パッケージング細胞
US5643756A (en) 1992-08-28 1997-07-01 The Public Health Research Institute Of The City Of New York, Inc. Fusion glycoproteins
JPH06261764A (ja) * 1993-02-17 1994-09-20 Wisconsin Alumni Res Found 混合型ｌｔｒ含有超複合型レトロウイルス及びその使用方法
DE4318387A1 (de) * 1993-06-03 1994-12-08 Bayer Ag Rekombinante Foamy Virus Vektoren für medizinische und diagnostische Anwendungen sowie Verfahren zur Herstellung von rekombinanten Foamy Virus Vektoren
FR2707091B1 (fr) 1993-06-30 1997-04-04 Cohen Haguenauer Odile Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes.

Also Published As

Publication number Publication date
DE69535024D1 (de) 2006-07-06
AU4306996A (en) 1996-06-19
IL116216A0 (en) 1996-01-31
FR2727429B1 (fr) 1997-11-28
WO1996017071A1 (fr) 1996-06-06
EP0796338A1 (de) 1997-09-24
JPH10510163A (ja) 1998-10-06
FR2727429A1 (fr) 1996-05-31
US6432709B1 (en) 2002-08-13
EP0796338B1 (de) 2006-05-31
IL116216A (en) 2007-02-11
CA2206574A1 (fr) 1996-06-06

Similar Documents

Publication Publication Date Title
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
MY125594A (en) Immortalized cell lines for virus growth
BR0009362A (pt) Variante de uma alfa-amilase semelhante atermamyl precursora, construção de dna, vetorde expressão recombinante, célula, composição,processo para gerar uma variante de umaalfa-amilase semelhante a termamyl precursora,e, uso de uma variante de alfa-amilase
EA199800566A1 (ru) Аденовирусный вектор (варианты), способ его получения, применение, репликационно-компетентное не содержащее аденовирус потомство, способ повышения размножения в комплементирующей клеточной линии аденовирусного вектора, способ генетической модификации клетки, композиция, клетка-хозяин, способ тестирования токсичности аденовирусного вектора, способ тестирования экспрессии чужеродного гена или гена-пассажира аденовирусного вектора
EP1757689A3 (de) Säugetiere Apoptosis-Inhibitorprotein Genfamilie, Primers, Proben und Verfahren zum Nachweis
HUP9900050A1 (hu) Rekombináns adenovírusok, és felhasználásuk adeno-asszociált vírusok (AAV) előállítására, komplementáló sejtvonalak, és az illető adenovírusokat tartalmazó gyógyszerkészítmények
ATE328095T1 (de) Verbesserungen des stärkegehaltes von pflanzen
WO2002002783A3 (en) Expression vectors
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
ES2118140T3 (es) Procedimiento de modificacion genetica de las celulas de la medula osea de primates, y celulas utilizables y celulas que producen vectores retrovirales recombinados.
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
WO2001004282A3 (en) Replication-competent anti-cancer vectors
WO1999028488A3 (de) Retrovirale pseudotyp-vektoren mit modifizierten oberflächen-hüllproteinen und verfahren zu ihrer herstellung für den selektiven gentransfer
ATE386130T1 (de) Adenovirale vektoren für die gentherapie
ATE328100T1 (de) Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren
WO2001004283A3 (en) Organic anion transporter genes and proteins
FR2778670B1 (fr) Methodes et compositions pour la production de particules virales
PT880594E (pt) Vector retroviral e sua utilizacao em terapia genica
ATE342998T1 (de) Replikation -defektive baculoviren expressionssystem
DK0658626T3 (da) Fremgangsmåder til produktion af protein C
CA2146240A1 (en) Increased production of secreted proteins by recombinant eukaryotic cells
Sakurai et al. Subunit composition of RNA polymerase II from the fission yeast Schizosaccharomyces pombe
ATE96838T1 (de) Expressionsvektor und verfahren zur expression von heterologen proteinen in saeugerzellen.
DK0994955T3 (da) Öget produktion af secernerede proteiner med rekombinante gærceller

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties